- Home
- » Tags
- » Receptor tyrosine kinase
Top View
- C-Kit Receptor and Ligand Expression in Postnatal Development of the Mouse Cerebellum Suggests a Function for C-Kif in Inhibitory Interneurons
- Small Molecule Tyrosine Kinase Inhibitors of Erbb2/HER2/Neu in the Treatment of Aggressive Breast Cancer
- Receptor Tyrosine Kinase Signalling As a Target for Cancer Intervention Strategies
- The Tyrosine Kinase Regulator Cbl Enhances the Ubiquitination and Degradation of the Platelet-Derived Growth Factor Receptor ␣
- Harnessing the Power of Eph/Ephrin Biosemiotics for Theranostic Applications
- Eph Receptors and Ephrin Ligands: Embryogenesis to Tumorigenesis
- Eph/Ephrin Signaling: Networks
- Mouse Platelet-Derived Growth Factor Receptor a Gene Is Deleted in WJ9H and Patch Mutations on Chromosome 5 E
- Regulation of PDGFR Signaling
- THE ROLE of the Ret PROTO-ONCOGENE in HUMAN DISEASE
- Studies of PDGF Receptor Signaling in Vitro and in Vivo
- C-Met and Other Cell Surface Molecules: Interaction, Activation and Functional Consequences
- The Role of Epidermal Growth Factor Receptor Family of Receptor Tyrosine Kinases in Mediating Diabetes-Induced Cardiovascular Complications
- A Tyrosine Kinase-Activating Variant Asn666ser in PDGFRB Causes a Progeria-Like Condition in the Severe End of Penttinen Syndrome
- Mechanisms of Receptor Tyrosine Kinase Activation in Cancer Zhenfang Du1 and Christine M
- Exploiting Insights on the RET Receptor for Personalized Cancer Medicine
- Structure and Regulation of Kit Protein-Tyrosine Kinase—The Stem Cell Factor Receptor Q
- De-Repression of Pdgfrb Transcription Promotes Acquired
- TNF Down-Regulation of Receptor Tyrosine Kinase
- Expression and Function of the Eph Receptor
- Oncogenic Mutation in the Kit Receptor Tyrosine Kinase Alters Substrate
- Appendix 3 Eph/Ephrin Receptor Crosstalk
- Erbb3/HER3 Intracellular Domain Is Competent to Bind ATP and Catalyze Autophosphorylation
- Structure and Physiology of the RET Receptor Tyrosine Kinase
- Molecular Mechanisms of Cardiotoxicity Induced by Erbb Receptor Inhibitor Cancer Therapeutics
- Signaling by Non-Canonical Receptor Tyrosine Kinases ERBB3 and RYK
- Eph/Ephrin Molecules—A Hub for Signaling and Endocytosis
- Oncogene C-Kit in a Human Mast Cell Leukemia Cell Line Causing Ligand-Independent Activation of C-Kit Product
- Eph Receptor Tyrosine Kinases in Tumor Immunity Eileen Shiuan1,2 and Jin Chen1,3,4,5,6
- A Novel Type of Mutation in the Cysteine Rich Domain of the RET Receptor Causes Ligand Independent Activation
- Oncogenic Activation of the Met Receptor Tyrosine Kinase Fusion Protein, Tpr–Met, Involves Exclusion from the Endocytic Degradative Pathway
- Molecular Pathways Targeting RET Receptor Tyrosine Kinase Activation in Cancer John E. Phay1 and Manisha H. Shah2 Affiliations
- Role of the HGF/C-MET Tyrosine Kinase Inhibitors in Metastasic Melanoma Lucia Demkova and Lucia Kucerova*
- KIT Gene KIT Proto-Oncogene Receptor Tyrosine Kinase
- Identification of the Receptor Tyrosine Kinase C-Met and Its Ligand, Hepatocyte Growth Factor, As Therapeutic Targets in Clear Cell Sarcoma
- Epithelial Cells and Provides a Regulatory Link to Lung Ephrin-A1
- PDGFRA Alterations in Cancer: Characterization of a Gain-Of-Function V536E Transmembrane Mutant As Well As Loss-Of-Function and Passenger Mutations
- The Erbb3 Receptor Tyrosine Kinase Negatively Regulates Paneth Cells by PI3K-Dependent Suppression of Atoh1
- The Receptor Tyrosine Kinase Erbb3 Maintains the Balance Between Luminal and Basal Breast Epithelium
- Functional Analysis of Receptor Tyrosine Kinase Mutations in Lung Cancer Identifies Oncogenic Extracellular Domain Mutations of ERBB2
- Insights Into Eph Receptor Tyrosine Kinase Activation from Crystal Structures of the Epha4 Ectodomain and Its Complex with Ephrin-A5
- Cells and Epha Receptor Down-Regulation in T Ephrin-A1
- Mechanisms of Activation of Receptor Tyrosine Kinases: Monomers Or Dimers
- Tyrosine Kinase Receptors in Oncology